Clinical Research Papers:
Optimal hydration volume among high-risk patients with advanced congestive heart failure undergoing coronary angiography
Metrics: PDF 593 views | HTML 1564 views | ?
Shi-Qun Chen1,2,*, Yong Liu1,3,*, Wei Jie Bei1,*, Ying Wang3,*, Chong-Yang Duan4,*, Deng-Xuan Wu1,*, Kun Wang1, Ping Yan Chen4, Ji-Yan Chen1, Ning Tan1 and Li-Wen Li1
1Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China
2Department of Cardiology, Guangdong General Hospital Zhuhai Hospital (Zhuhai Golden Bay Center Hospital), Zhuhai, Guangdong, China
3The George Institute for Global Health, Sydney, Australia
4National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Department of Biostatistics, School of Public Health and Tropical Medicine Southern Medical University, Guangzhou, Guangdong, China
*These authors contributed equally to this work
Li-Wen Li, email: firstname.lastname@example.org
Ning Tan, email: email@example.com
Keywords: heart failure; acute kidney injury; hydration; contrast; coronary angiography
Received: May 30, 2017 Accepted: March 10, 2018 Published: May 04, 2018
We investigated the relationship between weight-adjusted hydration volumes and the risk of developing contrast-induced acute kidney injury (CI-AKI) and worsening heart failure (WHF) and explored the relative safety of optimal hydration volumes in patients with advanced congestive heart failure (CHF) undergoing coronary angiography (CAG) or percutaneous coronary intervention. We included 551 patients with advanced CHF (New York Heart Association class > 2 or history of pulmonary edema) undergoing CAG (follow-up period 2.62 ± 0.9 years). There was a significant association between hydration volume-to-weight ratio (HV/W) (quintile Q1, Q2, Q3, Q4, and Q5) and the incidence of CI-AKI (3.7%, 14.6%, 14.3%, 21.1%, and 31.5%, respectively) and WHF (3.6%, 5.4%, 8.3%, 13.6%, and 19.1%, respectively) (all P-trend < 0.001). Receiver operating curve analysis indicated that HV/W = 15 mL/kg and the mean HV/W (60.87% sensitivity and 64.96% specificity) were fair discriminators for CI-AKI (C-statistic 0.696). HV/W >15 mL/kg independently predicted CI-AKI (adjusted odds ratio [OR] 2.33; P = 0.016) and WHF (adjusted OR 2.13; P = 0.018). Moreover, both CI-AKI and WHF were independently associated with increased long-term mortality. Thus, for high-risk patients with advanced CHF undergoing CAG, HV/W > 15 mL/kg might be associated with an increased risk of developing CI-AKI and WHF. The potential benefits of a personalized limitation of hydration volume need further evaluation.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.